Eiger BioPharmaceuticals ($EIGR) announced inking a new deal with Theragene Pharmaceuticals to sell Mydicar (rAAV1-SERCA2a) for $3.1 million. Eiger will be eligible to receive milestones up to $15 million and royalties on net sales. Mydicar is a cardiovascular gene therapy product that uses an adeno-associated virus (AAV) to deliver a certain protein to cardiac cells.
Walgreens ($WBA) announced its new collaboration with LabCorp ($LH) for eveloping and operating patient service centers within certain Walgreens stores this year. Seven sites including five in Denver, CO, one in Morrisville, NC and one in Deerfield, IL. will begin seeing patients this year.